In the process of development or oncogenesis, genes might be silenced through promoter methylation. In tumors, promoters of tumor suppressor genes such as Apaf-1 and caspase 8 are frequent targets of methylation. Methylation inhibitors such as 5-azacytidine reactivate expression of these tumor suppressor genes, potentially contributing to anticancer therapy.